Trial Profile
Investigator-Initiated, Use Study of Alefacept (Amevive) in Combination With Tapering Doses of Cyclosporine in Patients With Moderate to Severe Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Alefacept (Primary) ; Ciclosporin
- Indications Psoriasis
- Focus Therapeutic Use
- 19 Nov 2013 New trial record